
浏览全部资源
扫码关注微信
1. 新疆医科大学附属肿瘤医院1. 病理科
2. 医务部,乌鲁木齐,830011
纸质出版日期:2012,
扫 描 看 全 文
李文婷, 王 莹, 张银华, 等. 年轻女性乳腺癌中ER、PR、HER-2和Ki67的表达与临床病理意义[J]. 重庆医科大学学报, 2012,37(9):783-786.
LI Wenting, WANG Ying, ZHANG Yinhua, et al. Expressions and clinical significances of ER,PR,HER-2 and Ki67 in young women with breast carcinoma[J]. Journal of Chongqing Medical University, 2012,37(9):783-786.
李文婷, 王 莹, 张银华, 等. 年轻女性乳腺癌中ER、PR、HER-2和Ki67的表达与临床病理意义[J]. 重庆医科大学学报, 2012,37(9):783-786. DOI:
LI Wenting, WANG Ying, ZHANG Yinhua, et al. Expressions and clinical significances of ER,PR,HER-2 and Ki67 in young women with breast carcinoma[J]. Journal of Chongqing Medical University, 2012,37(9):783-786. DOI:
目的:探讨雌激素受体(Estrogen receptor,ER)、孕激素受体(Progesterone receptor,PR)、人表皮生长因子受体-2(Hu-man epidemic growth factor receptor-2,HER-2)和Ki67在新疆地区年轻女性(≤35岁)乳腺癌(Breast carcinoma,BC)患者中的表达及其与临床病理特征的关系。方法:应用免疫组化法检测70例年轻女性BC组织中ER、PR、HER-2和Ki67的表达情况,分析其表达与临床病理特征的关系。结果:(1)70例年轻女性BC中,ER、PR、HER-2和Ki67的阳性率分别为74.3%(52/70)、71.40%(50/70)、32.90%(23/70)和97.1%(68/70);(2)HER-2表达在肿瘤大小及淋巴结转移各组中的差异有统计学意义(P<0.05);Ki67表达在民族、组织学分级和淋巴结转移各组中的差异有统计学意义(P<0.05);(3)ER、PR表达在民族、组织学分级、肿瘤大小及淋巴结转移各组中的差异均无统计学意义(P >0.05);HER-2表达在民族和组织学分级各组中的差异均无统计学意义(P >0.05);Ki67表达在肿瘤大小组中的差异均无统计学意义(P >0.05)。结论:(1)ER、PR在年轻女性BC中表达较高,其表达与临床病理特征无关;(2)HER-2和Ki67表达与年轻女性BC恶性度分级和转移有关;(3)Ki67在年轻女性BC中表达较高,且在不同民族中的表达存在差异;(4)联合检测ER、PR、HER-2和Ki67可作为判定年轻女性BC生物学行为和预后的参考指标。
Objective:To discuss the expressions of estrogen receptor(ER),progesterone receptor(PR),human epidemic receptor-2 (HER-2) and Ki67 in young women(≤35 years old) with breast carcinoma in Xinjiang and to explore the relationship between the expressions and the clinical pathological characteristics. Methods:The expressions of ER,PR,HER-2 and Ki67 in 70 young women with breast cancer were detected by immunohistochemical method and their relationship with the clinical pathological characteristics was analyzed. Results:The positive rate of ER,PR,HER-2 and Ki67 in 70 young women with breast carcinoma of were 74.3%(52/70),71.40%(50/70),32.90%(23/70) and 97.1%(68/70). Statistical differences in the expressions of HER-2 were observed in groups with different tumor sizes and groups with or without lymph node metastasis(P<0.05);statistical differences in the expressions of Ki67 were observed in groups with different nationalities and histological gradings and groups with or without lymph node metasta-sis(P<0.05). No statistical difference in the expression of ER and PR was observed in groups with different nationalities and histologi-cal gradings,groups with different tumor sizes and groups with or without lymph node metastasis(P >0.05);no statistical difference in the expression of HER-2 was observed in groups with different nationalities and histological gradings(P >0.05);no statistical difference in the expression of Ki67 was observed in groups with different tumor sizes(P >0.05). Conclusions:(1)The expressions of ER and PR in young women with breast carcinoma are high,but the expressions are not related with clinical pathological features.(2)The expres-sions of HER-2 and Ki67 are related with malignancy grading and metastasis. (3)The expressions of Ki67 are high and show vari-ances in groups with different nationalities. (4)Combined detection of ER,PR,HER-2 and Ki67 can be used as criterion of biologi-cal behavior and prognosis in young women with breast carcinoma.
乳腺癌雌激素受体孕激素受体人表皮生长因子受体-2Ki67免疫组化
breast carcinomaestrogen receptorprogesterone receptorhuman epidemic receptor-2Ki67immunohistochemistry
0
浏览量
610
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621